Basic statistical analysis in genetic case-control studies.

Genetic and Genomic Epidemiology Unit, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Nature Protocol (Impact Factor: 8.36). 02/2011; 6(2):121-33. DOI: 10.1038/nprot.2010.182
Source: PubMed

ABSTRACT This protocol describes how to perform basic statistical analysis in a population-based genetic association case-control study. The steps described involve the (i) appropriate selection of measures of association and relevance of disease models; (ii) appropriate selection of tests of association; (iii) visualization and interpretation of results; (iv) consideration of appropriate methods to control for multiple testing; and (v) replication strategies. Assuming no previous experience with software such as PLINK, R or Haploview, we describe how to use these popular tools for handling single-nucleotide polymorphism data in order to carry out tests of association and visualize and interpret results. This protocol assumes that data quality assessment and control has been performed, as described in a previous protocol, so that samples and markers deemed to have the potential to introduce bias to the study have been identified and removed. Study design, marker selection and quality control of case-control studies have also been discussed in earlier protocols. The protocol should take ~1 h to complete.


Available from: Krina T Zondervan, Apr 19, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Genome-wide association studies of type 2 diabetes have been extremely successful in discovering loci that contribute genetic effects to susceptibility to the disease. However, at the vast majority of these loci, the variants and transcripts through which these effects on type 2 diabetes are mediated are unknown, limiting progress in defining the pathophysiological basis of the disease. In this review, we will describe available approaches for assaying genetic variation across loci and discuss statistical methods to determine the most likely causal variants in the region. We will consider the utility of trans-ethnic meta-analysis for fine mapping by leveraging the differences in the structure of linkage disequilibrium between diverse populations. Finally, we will discuss progress in fine-mapping type 2 diabetes susceptibility loci to date and consider the prospects for future efforts to localise causal variants for the disease.
    Current Diabetes Reports 11/2014; 14(11):549. DOI:10.1007/s11892-014-0549-2 · 3.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatoid arthritis and osteoporosis are major causes of disability associated with aging and are increasing in public health importance. Biostatisticians work to advance public health through biomedical research. Polymorphisms allow not only the detection of susceptible individuals to a certain disease but also the evaluation of the severity of the disease. The aim of this research is to study the influence of vitamin D receptor polymorphisms on rheumatoid arthritis patients with or without osteoporosis. Osteoporosis is a measurement of rheumatoid arthritis severity in the affected patients. Four single nucleotide polymorphisms (ApaI, BsmI, FokI, and TaqI) were tested by genotyping 17 rheumatoid arthritis patients with osteoporosis and 72 rheumatoid arthritis patients without osteoporosis. Associations were tested using multiplicative, dominant, recessive, and co-dominant models. Also, the linkage disequilibrium between the polymorphisms was measured to detect any indirect variant. The FokI variant was significantly associated with risk of osteoporosis in rheumatoid arthritis.
    7th Cairo International Biomedical Engineering Conference (CIBEC 2014), Giza, Egypt; 12/2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinase-1 (MMP-1), an interstitial collagenase, is responsible for the proteolytic degradation of basement membrane and extracellular matrix. MMP-1 plays a major role in the invasion of gastric cancer (GC). The role of the genetic polymorphisms in the functional regions of MMP-1 on the risk of GC remains unclear. To identify the markers that contribute to the genetic susceptibility to GC, we examined the potential association between GC and nine single-nucleotide polymorphisms (rs1799750, rs498186, rs475007, rs514921, rs494379, rs996999, rs2071232, rs1938901, and rs2239008) of the MMP-1 gene using the MassARRAY system in this study. The participants enrolled in this study included 422 patients with GC and 428 healthy subjects as the healthy controls from a Chinese Han population. The analysis revealed a weak association between the rs1799750 (in the promoter region) genotype distribution and GC (p=0.020). The frequency of the 2G allele was significantly higher in the patients with GC than in the healthy controls (p=0.005, odds ratio [OR]=1.324, 95% confidence interval [CI]: 1.087-1.613). Moreover, the patients with the 2G/2G genotype of rs1799750 had a significantly increased risk of cancer invasion compared with patients with the 1G/1G+1G/2G genotype (p=0.001, OR=0.505, 95% CI: 0.331-0.771). Strong linkage disequilibrium was observed in three blocks (D'>0.9). Significantly, more C-2G haplotypes (block 3) (p=0.0005 after Bonferroni correction) were found in GC subjects. These findings point to a role for MMP-1 promoter polymorphism in GC among a Han Chinese population, and may be informative for future genetic or biological studies on GC.
    Genetic Testing and Molecular Biomarkers 08/2014; 18(10). DOI:10.1089/gtmb.2014.0117 · 1.15 Impact Factor